STABLE LIQUID PHARMACEUTICAL COMPOSITIONS OF BORTEZOMIB Abstract The present invention relates to stable ready to use liquid pharmaceutical formulations of Bortezomib or a pharmaceutically acceptable salt thereof. Further the present invention relates to pharmaceutical composition of Bortezomib comprising a solvent or mixture of solvents and other pharmaceutically acceptable adjuvants thereof.